Search Within

Gunjan Lalitchandra Shah

Formats
  1. Meeting Abstract (291)
  2. Journal Article (132)
  3. Research Letter (15)
  4. Review (6)
  5. Correspondence (3)
  6. Guidelines (1)
Groups
  1. Bone Marrow Transplant (448)
  2. Center for Hematologic Malignancies (448)
  3. Department of Medicine (448)
  4. Hematologic Malignancies, Division of (448)
  5. Survivorship Research (448)
  6. Hematology-Oncology Fellows (347)

More Groups

People
  1. Sergio Giralt (311)
  2. Michael Scordo (299)
  3. Miguel-Angel Perales (204)
  4. Sean Devlin (187)
  5. Heather Landau (164)
  6. Parastoo Dahi (163)

More People

Years
  1. 2025 (24)
  2. 2024 (72)
  3. 2023 (85)
  4. 2022 (55)
  5. 2021 (31)
  6. 2020 (51)

More Years

Publications
  1. Blood (156)
  2. Biology of Blood and Marrow Transplantation (73)
  3. Clinical Lymphoma, Myeloma and Leukemia (39)
  4. Transplantation and Cellular Therapy (23)
  5. Blood Advances (22)
  6. Bone Marrow Transplantation (19)

More Publications

Publishers
  1. American Society of Hematology (178)
  2. Elsevier Inc. (143)
  3. Nature Publishing Group (33)
  4. American Society of Clinical Oncology (15)
  5. Taylor & Francis Group (9)
  6. Wiley Blackwell (8)

More Publishers

Results (448)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Transformed indolent lymphoma outcomes similar to de novo diffuse large B-cell lymphoma after autologous hematopoietic stem cell transplantation (AHCT), but not allogeneic HCT (allo-HCT)
    Meeting Abstract

    Pathak, P.; Shah, G. L.; Tsyvkin, E.; Maloy, M.; Knezevic, A.; Devlin, S. M.; Giralt, S. A.; Matasar, M. J.; Moskowitz, C. H.; Sauter, C. S.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Prevalence of functional impairment and geriatric vulnerability during pre-transplant geriatric assessment in an academic hematopoietic cell transplantation center
    Meeting Abstract

    Lin, R. J.; Perales, M. A.; Shahrokni, A.; Maloy, M.; Devlin, S. M.; Jakubowski, A. A.; Dahi, P. B.; Shah, G. L.; Korc-Grodzicki, B.; Giralt, S. A.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Engraftment kinetics after high-dose melphalan autologous stem cell transplant in patients with multiple myeloma
    Meeting Abstract

    Bachier-Rodriguez, L.; Shah, G. L.; Knezevic, A.; Devlin, S. M.; Maloy, M.; Koehne, G.; Chung, D. J.; Landau, H.; Giralt, S. A.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Feasibility and toxicity of Pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S.; Hoover, E.; Chung, D. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Therapeutic cyclosporine-a (CSA) levels in the first 7 days after cord blood transplantation (CBT) are critical to prevent severe acute graft-versus-host disease (aGVHD)
    Meeting Abstract

    Bhatt, V.; Politikos, I.; Devlin, S. M.; Jacob, A. G.; Maloy, M.; Naputo, K.; Afuye, A.; Scaradavou, A.; O'Reilly, R. J.; Castro-Malaspina, H.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Long-term follow-up of adult double unit cord blood (CB) transplantation (dCBT) recipients reveals high rates of progression-free survival after a novel Cy/ Flu/ Thio/ TBI 400 intermediate intensity conditioning regimen
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Jacob, A. G.; Maloy, M.; Mazis, C.; Naputo, K.; Afuye, A.; Scaradavou, A.; O'Reilly, R. J.; Avecilla, S. T.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Toxicities associated with high dose chemotherapy and autologous stem cell transplantation in older patients with non-Hodgkin lymphoma
    Meeting Abstract

    Dahi, P. B.; Rondon Clavo, C.; Maloy, M.; Seier, K.; Devlin, S. M.; Robinson, K.; Scordo, M.; Shah, G. L.; Tamari, R.; Matasar, M. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with hematopoietic stem cell transplant (HCT) for multiple myeloma (MM), AL amyloidosis (AL), lymphoma, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS)
    Meeting Abstract

    Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S.; Devlin, S. M.; Castro-Malaspina, H.; Chung, D. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Empiric anti-thymocyte globulin (ATG) dosing in ex-vivo CD34-selected myeloablative allogeneic hematopoietic cell transplantation (allo-HCT) may result in ATG overexposure that negatively affects outcomes
    Meeting Abstract

    Scordo, M.; Bhatt, V.; Smith, M.; Thoren, K.; Hilden, P.; Cho, C.; Shah, G. L.; Maloy, M.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Checkpoint inhibition in lymphoma
    Journal Article

    Shah, G. L.; Moskowitz, C. H.
    Clinical Advances in Hematology & Oncology (2018)

    Fulltext@MSK | Save